8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector
The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive
The Awards recognizes standout digital health & medical technology products and companies
The partnership will capitalize on the combined capabilities of the two organizations
The acquisition is for an enterprise value of Rs. 218 crores
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
Subscribe To Our Newsletter & Stay Updated
